IOL Chemicals and Pharmaceuticals has secured Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & Health Care (EDQM) for its API product ‘CLOPIDOGREL BESILATE’ on February 23, 2026. The company has an existing valid CEP for ‘CLOPIDOGREL BISULPHATE.’ Clopidogrel is an antiplatelet medication used in the treatment and prevention of cardiovascular diseases.
IOL Chemicals and Pharmaceuticals is India's one of the leading generic pharmaceutical companies, and is significant player in the Organic chemicals space.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1660.60 |
| Dr. Reddys Lab | 1213.50 |
| Cipla | 1227.25 |
| Zydus Lifesciences | 926.45 |
| Lupin | 2294.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: